|
G |
Dhh |
desert hedgehog signaling molecule |
|
IMP |
|
RGD |
PMID:21062903 |
RGD:38548923 |
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
|
|
|
G |
Dhh |
desert hedgehog signaling molecule |
|
IMP |
|
RGD |
PMID:21062903 |
RGD:38548923 |
NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406
|
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 compared to wild type and heterozygotes |
RGD |
PMID:19500159 PMID:17803050 PMID:18676360 |
RGD:150429979, RGD:150429978, RGD:150429974 |
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 PMID:19500159 PMID:17803050 |
RGD:150429974, RGD:150429979, RGD:150429978 |
|
|
|
G |
Atm |
ATM serine/threonine kinase |
|
IMP |
DNA:deletion:exon: |
RGD |
PMID:27895165 PMID:28007901 |
RGD:12879393, RGD:12879399 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atmem1Kyo |
ATM serine/threonine kinase; ZFN induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:28007901 |
RGD:12879399 |
|
|
G |
Atmm1Kyo |
ATM serine/threonine kinase; ENU induced mutant 1, Kyo |
|
IMP |
|
RGD |
PMID:27895165 |
RGD:12879393 |
|
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Ahrem2Sage |
aryl hydrocarbon receptor; ZFN induced mutant2, Sage |
|
IMP |
compared to Hsd:SD |
RGD |
PMID:23859880 |
RGD:13204753 |
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
|
IMP |
|
RGD |
PMID:25934999 |
RGD:11085488 |
NCBI chr 1:205,731,828...205,743,430
Ensembl chr 1:205,733,872...205,743,421
|
|
G |
Bscl2m1Kyo |
BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:25934999 |
RGD:11085488 |
|
|
G |
Dnd1 |
DND microRNA-mediated repression inhibitor 1 |
|
IAGP |
compared to WKY and heterozygous |
RGD |
PMID:22655094 |
RGD:40924659 |
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
|
|
G |
Dnd1ter |
DND microRNA-mediated repression inhibitor 1, ter mutant |
|
IAGP |
compared to WKY and heterozygous |
RGD |
PMID:22655094 |
RGD:40924659 |
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
G |
Sbf1 |
SET binding factor 1 |
|
IAGP |
DNA:substitution:intron 37:G>A (rat) |
RGD |
PMID:27335132 |
RGD:38549340 |
NCBI chr 7:120,358,338...120,385,022
Ensembl chr 7:120,358,338...120,384,902
|
|
G |
Sbf1m1Ipcv |
SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences |
|
IAGP |
|
RGD |
PMID:27335132 |
RGD:38549340 |
|
|
G |
Spata22 |
spermatogenesis associated 22 |
treatment |
IDA |
|
RGD |
PMID:23903057 |
RGD:38549346 |
NCBI chr10:57,945,272...57,963,081
Ensembl chr10:57,932,187...57,963,081
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
|
RGD |
PMID:28834365 |
RGD:14995504 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53em1Sage |
tumor protein p53; ZFN induced mutant 1, Sage |
|
IMP |
compared to SD |
RGD |
PMID:28834365 |
RGD:14995504 |
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 PMID:17803050 |
RGD:150429974, RGD:150429978 |
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 PMID:17803050 |
RGD:150429974, RGD:150429978 |
|
|
|
G |
Fmr1 |
fragile X messenger ribonucleoprotein 1 |
|
IMP |
DNA:deletion:intron 7, exon 8: |
RGD |
PMID:24773431 PMID:30877790 PMID:28894415 |
RGD:9831152, RGD:38548928, RGD:38501107 |
NCBI chr X:147,240,239...147,278,057
Ensembl chr X:147,240,301...147,278,050
|
|
G |
Fmr1em1Mzhe |
FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe |
|
IMP |
|
RGD |
PMID:28894415 |
RGD:38501107 |
|
|
G |
Fmr1em1Sage |
FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
DNA:deletion:intron 7, exon 8: |
RGD |
PMID:24773431 PMID:30877790 |
RGD:9831152, RGD:38548928 |
|
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
compared to SD |
RGD |
PMID:28834365 |
RGD:14995504 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53em1Sage |
tumor protein p53; ZFN induced mutant 1, Sage |
|
IMP |
compared to SD |
RGD |
PMID:28834365 |
RGD:14995504 |
|
|
|
G |
Tp53 |
tumor protein p53 |
|
IMP |
compared to SD |
RGD |
PMID:28834365 |
RGD:14995504 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53em1Sage |
tumor protein p53; ZFN induced mutant 1, Sage |
|
IMP |
compared to SD |
RGD |
PMID:28834365 |
RGD:14995504 |
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
|
|
|
G |
Adamts16 |
ADAM metallopeptidase with thrombospondin type 1 motif, 16 |
|
IMP |
|
RGD |
PMID:24983376 |
RGD:13434925 |
NCBI chr 1:32,430,436...32,562,481
Ensembl chr 1:32,430,436...32,560,494
|
|
G |
Adamts16em1Bj |
ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj |
|
IMP |
|
RGD |
PMID:24983376 |
RGD:13434925 |
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
IMP |
|
RGD |
PMID:12754522 |
RGD:727990 |
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Brca2m1Uwm |
BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison |
|
IMP |
|
RGD |
PMID:12754522 |
RGD:727990 |
|
|
|
G |
Dnd1 |
DND microRNA-mediated repression inhibitor 1 |
|
IAGP |
compared to WKY |
RGD |
PMID:22655094 |
RGD:40924659 |
NCBI chr18:28,378,692...28,381,316
Ensembl chr18:28,378,692...28,381,316
|
|
G |
Dnd1ter |
DND microRNA-mediated repression inhibitor 1, ter mutant |
|
IAGP |
compared to WKY |
RGD |
PMID:22655094 |
RGD:40924659 |
|
|
|
G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
IAGP |
DNA:missense mutation:cds:G369E (rat) |
RGD |
PMID:27472223 |
RGD:39131293 |
NCBI chr 1:182,515,335...182,520,007
Ensembl chr 1:182,515,327...182,536,633
|
|